You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海凱寶(300039.SZ):與上海交通大學共建聯合研發中心
格隆匯 11-23 19:51

格隆匯11月23日丨上海凱寶(300039.SZ)公佈,近日,公司(“乙方”)控股子公司上海凱合交醫療科技有限公司(“凱合交”、“ 方”、“ 子公司”)與上海交通大學(“上海交大”、“甲方”)三方協商一致,簽訂了《共建上海交通大學-海凱寶藥業股份有限公司生物材料聯合研發中心協議》,本着優勢互補、共同發展的原則共建上海交通大學-上海凱寶藥業股份有限公司生物材料聯合研發中心(“聯合研發中心”)

凱合交委託上海交大實驗室對水凝膠生物材料,特別是在消毒和創面高效癒合材料上進行廣泛和系統的實驗及基礎理論研究開發新的技術和產品由凱合交進行產業孵化,用於創面癒合產品的生產經營。

公司堅持走產學研相結合的發展道路,本着優勢互補、共同發展的原則,海交大共建生物材料聯合研發中心,以手性材料應用於醫療器械及藥品等相關領域為方向共同研發,進一步拓展公司業務,符合公司多元化的戰略發展規劃通過聯合研發中心的建立,進一步推動三方公司在技術研發等方面的交流合作,對公司及子公司未來發展具有積極意義

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account